CTRI/2017/03/008011已完成未知
sage of Dapagliflozin - a Sodium Glucose Co-transporter inhibitor, in the management of Type-2 Diabetes Mellitus: A Real world evidence study in Indian patients - FOREFRONT
试验速览
- 阶段
- 未知
- 状态
- 已完成
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1. Patients who provide written informed consent.
- •2. Patients with previously diagnosed Type-2 diabetes mellitus
- •3. Patients with inadequately controlled diabetes (HbA1c >7%) with existing anti-diabetic medications, prior to initiation of dapagliflozin treatment.
- •4. Patients who are taking dapagliflozin within last 3 months.
- •5.Patients who are having past medical records for demographic information, weight, blood pressure and HbA1c value at the time of dapagliflozin prescribed
排除标准
- •1.Patients with Type-1 diabetes mellitus
- •2. Patients with any medical condition which in the opinion of the investigator would interfere with safe completion of the study
- •3. Pregnant or lactating women
研究者
相似试验
已完成
不适用
The study of dapagliflozin (sodium glucose cotransporter 2 inhibitor) to verify the efficacy of combination therapy in Japanese patients with type 2 diabetesType 2 diabetesJPRN-UMIN000015369Okayama University Hospital nephrology, diabates and endocrinology100
已完成
4 期
Effect of Dapagliflozin on Vascular Functions in Patients With Type 2 Diabetes Compared to GliclazideDiabetesNCT02610088Seoul National University Bundang Hospital32
已完成
不适用
Usage of Dapagliflozin in the Management of Type-2 Diabetes Mellitus: A Real World Evidence Study in Indian PatientsType 2 DiabetesNCT03071016AstraZeneca2,000
已完成
1 期
Pilot Study to Explore the Efficacy of DAPAglifozin as add-on to Closed-loop Control in Patients With Type 1 DiabetesType1diabetesNCT02987738Kinderkrankenhaus auf der Bult30
已完成
不适用
The potential effect of Dapagliflozin on diabetic macular edemadiabetic macular edema, diabetesJPRN-UMIN000020331Kyoto Prefectural University of Medicine Department of Endocrinology and Metabolism45